大型和低PEG脂质纳米颗粒使强效的mRNA癌症疫苗能够有效地向树突细胞
Xiaolan Xu1, Jiahao An2, Dan Bai1
1State Key Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
概括
大脂质纳米颗粒 (LLNPs) 增强信使RNA (mRNA) 向树突细胞 (DC) 的传递,以改善癌症疫苗. 这种新的平台显示出卓越的直流向和强大的抗瘤作用,为下一代免疫疗法铺平了道路.
科学领域:
- 免疫学 免疫学 免疫学
- 纳米技术纳米技术
- 在瘤学瘤学.
背景情况:
- 传递 RNA (mRNA) 癌症疫苗在有效向树突细胞 (DC) 输送方面面临着挑战.
- 优化脂质纳米粒子 (LNP) 配方对于提高疫苗疗效和DC向至关重要.
研究的目的:
- 开发和描述一个大尺寸的脂质纳米粒子 (LLNP) 平台,以改善DC向和mRNA传递.
- 评估LLNP在引起抗瘤免疫反应和实现瘤回归方面的有效性.
主要方法:
- 通过降低PEG脂质含量和增加结构脂质和mRNA度来改造LLNP.
- 在静脉注射后评估mRNA表达,DC成熟和抗原呈现 in vivo.
- 在瘤模型中使用HPV16 E6E7 mRNA评估LLNP介导的抗瘤疗效,并与现有平台进行比较.
主要成果:
- LLNP在DC中显著增强了mRNA递送和表达 (约82%的GFP+细胞是DC,约44%的CD11c+DC表达了GFP).
- LLNP促进了DC成熟和抗原呈现,导致了强大的细胞毒性T淋巴细胞反应.
- 基于LLNP的HPV16 E6E7 mRNA疫苗接种在低剂量 (1μg) 中实现了有效的瘤回归,并超过了商业RNA-lipoplex平台.
结论:
- LLNP为下一代mRNA癌症疫苗提供了一个有前途的平台,提供了卓越的DC向和增强的治疗潜力.
- 该LLNP平台促进了对常规1型和2型树突细胞的有效mRNA传递,cDC1s在抗原呈现中发挥着关键作用.
- LLNP为开发强效的mRNA癌症免疫疗法提供了一种多功能和强大的战略.
相关概念视频
Vaccinations
51.7K
Overview
51.7K
Cancer Vaccines
1.1K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K
Regulated mRNA Transport
7.0K
In eukaryotes, transcription and translation are compartmentalized; an mRNA is first synthesized in the nucleus and then selectively transported to the cytoplasm for protein synthesis. Before transport, a pre-mRNA undergoes several steps of post-transcriptional modifications including splicing, 5' capping, and the addition of a poly-adenine tail. Various proteins bind to the pre-mRNA during these modifications. The mRNA transport takes place with the help of multiple proteins playing...
7.0K
Targeted Cancer Therapies
8.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.9K
Nuclear Export of mRNA
8.8K
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
8.8K
pre-mRNA Processing
57.6K
In eukaryotic cells, transcripts made by RNA polymerase are modified and processed before exiting the nucleus. Unprocessed RNA is called precursor mRNA or pre-mRNA to distinguish it from mature mRNA.
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
57.6K


